MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical...
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase...
Generative AI Practitioners in Healthcare Prioritize Industry-Specific and Task-Specific Models as Budgets Surge 300%,...
John Snow Labs, the AI for healthcare company announced the findings of the inaugural Generative AI in Healthcare Survey. Conducted by Gradient Flow, the...
New Brigham Research Highlights Combining Prostate MRI with a Blood Test to Avoid Unnecessary...
A new meta-analysis by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, suggests that doctors and...
Preliminary Clinical Trial Results Show ‘Dramatic and Rapid Regression’ of Glioblastoma after Next Generation...
A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among...
Research Spotlight: A Two-Part Priming Strategy to Increase the Sensitivity of Liquid Biopsies
What Question Were You Investigating with this Study?Liquid biopsies, such as blood draws, can allow for the noninvasive diagnosis and monitoring of disease. The...
Lung Fibrosis is Seen Reversed in COVID Patients: Says Expert
Chronic Obstructive Pulmonary Disease (COPD) is currently the third leading cause of death globally. There are 300 million current cases of COPD in the...
Monoclonal Antibody Therapy 100% prevents Severe Disease and Deaths, says AIG Hospitals Study
The Monoclonal Antibody drug cocktail gained global attention as a miracle cure for COVID-19 ever since it got administered on ex-US president Donald Trump,...
Mauna Kea Technologies Announces New Clinical Study and Research Collaboration Agreement with the Lung...
Mauna Kea Technologies, inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy platform, announced that it has entered into a new research...
BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology
BioMed X, a leading independent research institute, announced the start of its eighth joint research program with Merck KGaA, Darmstadt, Germany. The new program...
Medtronic InPen RWD and Extended Infusion Set Pivotal Trial Results Demonstrate Strong Clinical Outcomes...
Medtronic plc, the global leader in medical technology, announced key clinical data from the virtual 81st annual American Diabetes Association Scientific Sessions. The presentations...
